10x Genomics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, 10x Genomics Inc 's inventory turnover ratio sequentially decreased to 3.07 in the third quarter 2026, otherwise the ratio remained above the average, as TXG's markets remain strong.10x Genomics Inc 's average inventory processing period in the Sep 30 2026 quarter, has increased to 119 days, from 111 days, in the Jun 30 2026 quarter.

Within Healthcare sector 117 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 979 in the second quarter 2026, to 1164.

TXG Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is 10x Genomics Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TXG Inventory Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Inventory Growth	4.31 %	-23.71 %	-28.41 %	-32.21 %	-34.12 %
Y / Y Cost of Sales Growth	-21.37 %	-18 %	-10.2 %	-0.12 %	6.67 %
Inventory Turnover Ratio (TTM)	3.07	3.29	3.21	3.02	2.74
TXG's Total Ranking	# 1164	# 979	# 312	# 1121	#
Average inventory processing period	119	111	114	121	133
Seq. Inventory Growth	22.83 %	-1.63 %	-5.07 %	-9.06 %	-10.17 %
Seq. Cost of Sales Growth	-2.07 %	-12.41 %	-18.52 %	12.5 %	2.13 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 4
Healthcare Sector	# 118
Overall Market	# 1164

Inventory Turnover Ratio Statistics
High	Average	Low
4.4	2.37	1.5
(Mar 31 2020)		(Mar 31 2022)

TXG Company Profile >> Back to TXG Efficiency Comparisons >> Compare TXG Inventory Turnover Ratio to its Competitors

Financial Statements
10x Genomics Inc 's Inventories	$ 65 Millions	Visit TXG's Balance sheet
10x Genomics Inc 's Cost of Revenues TTM	$ 174 Millions	Visit TXG's Income Statement
What are TXG's Sales?		Visit TXG's Sales by Segment

Other Inventory Turnover Ratios
10x Genomics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
TXG's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for TXG's Competitors
Inventory Turnover Ratio for TXG's Suppliers
Inventory Turnover Ratio for TXG's Customers

You may also want to know
TXG's Sales Growth Rates	TXG's Pe Price to earnings ratio	TXG's Receivables Turnover Ratio	TXG's Stock Quote
TXG's Net Income Growth Rates	TXG's Ps Price to Sales ratio	TXG's Sales per Employee	TXG's Asset Turnover Ratio
TXG's Net Margin	TXG's Pb Price to Book ratio	TXG's Financial Strength Ratios	TXG's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 30 2026	Inventories at quarter ending Sep 30 2026
Carlisle Companies Incorporated	6.99	$ 3,406.400 Millions	$ 488 Millions
Caredx Inc	6.42	$ 111.106 Millions	$ 17 Millions
Bristol myers Squibb Company	5.65	$ 15,389.000 Millions	$ 2,722 Millions
Avantor Inc	5.48	$ 4,539.200 Millions	$ 828 Millions
Tactile Systems Technology Inc	5.25	$ 82.718 Millions	$ 16 Millions
Integer Holdings Corporation	4.98	$ 1,376.268 Millions	$ 276 Millions
Ge Healthcare Technologies Inc	4.69	$ 11,372.000 Millions	$ 2,425 Millions
West Pharmaceutical Services Inc	4.69	$ 2,120.200 Millions	$ 452 Millions
Henry Schein Inc	4.63	$ 9,395.000 Millions	$ 2,031 Millions
Idexx Laboratories Inc	4.52	$ 1,743.379 Millions	$ 386 Millions
Medinotec Inc	4.28	$ 5.143 Millions	$ 1 Millions
3m Company	4.02	$ 15,267.000 Millions	$ 3,801 Millions
Novocure Limited	3.98	$ 166.721 Millions	$ 42 Millions
Incyte Corporation	3.79	$ 439.399 Millions	$ 116 Millions
Baxter International Inc	3.57	$ 8,117.000 Millions	$ 2,277 Millions
Bausch Health Companies Inc	3.54	$ 4,518.000 Millions	$ 1,276 Millions
Exelixis Inc	3.49	$ 93.324 Millions	$ 27 Millions
Abbvie Inc	3.40	$ 17,346.000 Millions	$ 5,108 Millions
Gilead Sciences Inc	3.30	$ 6,219.000 Millions	$ 1,884 Millions
Teva Pharmaceutical Industries Limited	3.16	$ 8,011.000 Millions	$ 2,537 Millions
Msa Safety Inc	3.00	$ 1,063.235 Millions	$ 354 Millions
Mimedx Group Inc	2.98	$ 70.562 Millions	$ 24 Millions
Ligand Pharmaceuticals Incorporated	2.93	$ 34.495 Millions	$ 12 Millions
Neogen Corporation	2.89	$ 464.774 Millions	$ 161 Millions
Zevra Therapeutics Inc	2.82	$ 6.736 Millions	$ 2 Millions
Biomerica Inc	2.65	$ 4.297 Millions	$ 2 Millions
Dexcom Inc	2.65	$ 1,867.500 Millions	$ 705 Millions
Angiodynamics Inc	2.50	$ 142.709 Millions	$ 57 Millions
Pro dex Inc	2.45	$ 53.753 Millions	$ 22 Millions
Illumina Inc	2.36	$ 1,458.000 Millions	$ 618 Millions

Date modified: 2026-11-07T07:05:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.